Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients. - Tohda, Y.; Fujimura, M.; Taniguchi, H.; Takagi, K.; Igarashi, T.; Yasuhara, H.; Takahashi, K.; Nakajima, S. (Clinical & Experimental Allergy, 2002)